CIK 0001504776
- Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 800423634
- Phone
- +1 646-847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion 10b5-1 | +26,511 | 193,390 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −10,984 | $16.67 | $183K | 182,406 |
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −58,455 | 0 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −8,880 | 94,717 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −5,096 | 23,781 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −1,981 | 5,283 | ||
| 2024-06-07 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Restricted Stock Units 10b5-1 | −10,554 | 154,798 | ||
| 2024-06-06 | Miller Steven Clive Chief Financial Officer | Exercise or conversion 10b5-1 | +10,601 | $13.08 | $139K | 181,926 |
| 2024-06-06 | Miller Steven Clive Chief Financial Officer | Exercise or conversion 10b5-1 | +662 | $12.35 | $8K | 182,588 |
| 2024-06-06 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −15,709 | $17.04 | $268K | 166,879 |
| 2024-06-06 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −10,601 | 0 | ||
| 2024-06-06 | Miller Steven Clive Chief Financial Officer | Exercise or conversion · Stock Option (Right to Buy) 10b5-1 | −662 | 58,455 | ||
| 2024-03-11 | Miller Steven Clive Chief Financial Officer | Sale 10b5-1 | −24,225 | $11.98 | $290K | 166,879 |
| 2024-03-08 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +52,065 | 64,371 | ||
| 2024-03-08 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −52,065 | $12.20 | $635K | 12,306 |
| 2024-03-08 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −52,065 | 6,615,635 | ||
| 2024-03-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +50,000 | 62,177 | ||
| 2024-03-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −50,000 | $12.40 | $620K | 12,177 |
| 2024-03-07 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −50,000 | 4,226,641 | ||
| 2024-03-06 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +28,311 | 40,617 |
Page 22 of 59 · 1,167 trades